The contribution of L-thyroxine (T4) to nuclear thyroid receptor occupancy was studied in GC cells incubated with concentrations of 3,5,3'-triiodo-L-thyronine (T3) and T4 that resulted in free iodothyronine levels similar to those in serum of euthyroid rats. T4 accounted for 5.4-10% of the occupied receptors: T3 derived from T4 1T3(T4)I and T3 added to medium accounted for the remainder of receptor occupancy. Incubation with increasing medium free T4 resulted in a progressive increase in the contribution of T4 and T3(T4) to receptor occupancy. In incubations with 3.6-fold increased medium free T4, T4 accounted for 20.4%, and T3(T4) for 40.3% of receptor occupancy. These occupancy data and the experimentally determined K. of thyroid receptor for T3 and T4 allowed calculation of nuclear free iodothyronine concentrations. Nuclear free T3 was 3-6-fold greater than medium free T3 and medium free T4 was 12-19-fold greater than medium free T4. When GC cells were incubated with decreased medium free T3 and physiological medium free T4, both nuclear receptor occupancy and growth hormone production decreased as well. However, a twofold increase in medium free T4, in the presence of decreased medium free T3, restored receptor occupancy and growth hormone production to or near control values. These findings establish a role for T4 in addition to T3(T4) in nuclear receptor occupancy and biological activity in rat anterior pituitary tissue both in physiologic conditions and when medium free T4 is raised. The findings may have relevance to the sick euthyroid thyroid syndrome in which free T4 may be increased in some patients who have decreased serum free T3. (J. Clin. Invest. 1991. 88:1291-1299.) Key words: L-triiodothyronine (T3) L-thyroxine (T4) nuclear free T3 and free T4* sick euthyroid syndrome * type II 5'-T4 monodeiodinase
Introduction
L-Thyroxine (T4) was reported in 1948 to be the circulating thyroid hormone by Taurog and Chaikoff (1) . The discovery of 3,5,3'-triiodo-L-thyronine (T3) in 1952 (2) and demonstration that T3 had greater biological activity than T4 (3) led Gross and Pitt-Rivers (2) to suggest that effects of T4 might result from deiodination to T3. However, experimental methods were not sufficiently sensitive to test this hypothesis at that time (4, 5) . Measurements of plasma T3 became available in 1970 (6) and investigators rapidly demonstrated that most of the extrathyroidal T3 pool in humans and rats was generated by deiodination ofT4 (7) (8) (9) . Moreover, conversion ofT4 to T3 was required for a major portion of the apparent activity of T4 (10) . These findings and the discovery that the nuclear thyroid hormone receptor had a greater affinity for T3 than for T4 (1 1, 12) suggested that T4 was mainly a prohormone, effecting biological responses by means of generated T3.
In euthyroid rats, T3 that is locally generated from T4 [T3(T4)]' within brain and anterior pituitary constitutes the principal source of nuclear T3, whereas nuclear T3 in liver and kidney is derived mainly from exchangeable plasma T3 [T3(T3)] (13, 14) . The role of T4 itself in occupancy of nuclear thyroid hormone receptors has not been established in anterior pituitary. Studies in euthyroid rats suggested that T4 constituted 10-15% of the endogenous iodothyronines specifically associated with thyroid nuclear receptors in liver and kidney (15) but was not detected in anterior pituitary (16, 17) . T4 was shown to have intrinsic biological activity by Samuels et al. (18) , who showed that T4 induced growth hormone (GH) production and thyroid nuclear receptor down-regulation in GH, cells in the absence ofappreciable conversion ofT4 to T3. More recently, others have shown that GH1 cells do generate appreciable amounts of T3 from T4 (19) .
Because interactions between iodothyronines and nuclear thyroid receptors are considered to initiate thyroid hormone action, the foregoing studies suggest that T4 itself effects 10-15% of the biological activity of thyroid hormones in liver and kidney. Although T4 affects biological activity in anterior pituitary by means ofT3(T4), these reports (16) (17) (18) (19) also suggest that the role of T4 itself in thyroid hormone action in anterior pituitary is not clearly defined. The issue is important for understanding both the action of thyroid hormones under physiologic conditions and during the alterations in plasma thyroid hormone concentrations that occur in patients with nonthyroidal disease. Unlike normal individuals, patients without thyroid disease who have an acute nonthyroidal illness are characterized by a decrease in the serum free T3 concentration and either a normal or increased concentration ofthe serum free T4 (20) (21) (22) . Data concerning the biological impact of the normal or raised concentrations of free T4 in this acute clinical setting have not been reported. It is not known, for example, whether the high concentration of free T4 in some patients with acute illness initiates biological activity which offsets the decrease in activity anticipated as a consequence of decreased concentrations of serum free T3.
Because ofthese uncertainties, we have investigated the role of T4 in the occupancy of nuclear thyroid hormone receptors using cultured GC cells, a well-characterized rat GH-producing cell line that is responsive to thyroid hormones. We have studied nuclear thyroid hormone receptor (TR) occupancy by T4 and T3 during incubation of GC cells in medium which contains free T4 and free T3 concentrations similar to those in euthyroid rats. Studies were also done in cells maintained in medium in which free T4 and free T3 were altered in a manner that is similar to patients with nonthyroidal disease.
Methods
Materials. L-T3, 3,5-diiodo-L-thyronine, L-T4, D-T3, D-T4, and Dowex 1 X8, 400-mesh anion exchange resin were purchased from Sigma Chemical Co., St. Louis, MO. T4 was purified by paper chromatography (22) . The content of T3 in the purified T4 was assessed by supplementing iodothyronine-depleted human serum (23) with the purified T4 and measuring T3 using a Clinical Assays Kit (Travenol Laboratories, Inc., Cambridge, MA). Using these methods, the purified T4prepa-rations contained < 0.05% T3. Dulbecco's modified Eagle's medium (DME), heat-inactivated calfand horse serum, and trypsin-EDTA were purchased from Gibco Laboratories, Grand Island, NY. Iopanoic acid was purchased from Chemical Dynamics Co., South Plainfield, NJ. Reagents for measurement of rat GH by radioimmunoassay (RIA) were a gift of the National Hormone according to the methods of Kochupillai and Yalow (24). Iodothyronines were purified as previously described (22) . 1'3'I]T3 had a specific activity of2.13 Ci/Mmol (3, 280 ,Ci/ug) and was > 95% pure as assessed by paper chromatography (22) [125IJT4 had a specific activity of 2.13 Ci/umol (2,750 uCi/;g) and contained < 0.1% of['25I]T3 as assessed by paper chromatography (22) . In that Freake et al. (25) coated charcoal as previously described (27) . The RIA for T4 has previously been validated for rat serum (27) . GH was measured by RIA according to the methods provided by the National Hormone and Pituitary Program, National Institutes ofHealth. The intra-and inter-assay coefficients of variation for all assays was < 10%. Free T4 and free T3 fractions were determined in undiluted rat serum by an ultrafiltration method previously described (22) . Free T4 and free T3 concentration in rat serum was then calculated as the product of the T3 and T4 concentrations and their respective free fractions.
Cell culture. Asynchronous monolayer cultures of GC cells were maintained in DME supplemented with 10% normal serum (calf/ horse, 2:1; NS-DME) as previously described (28) . Medium that was depleted of iodothyronines was prepared as follows: calf serum was treated with Dowex 1 X8, 400-mesh, anion exchange resin according to the procedure described by Samuels et al. (23) . This treatment was shown to decrease serum T4 (Clinical Assays Kit, Travenol Laboratories, Inc.) from 58.0 to 1.3 nM and serum T3 from 3.0 to < 0.05 nM (29) . DME containing 10% resin-treated serum alone (RT-DME) or RT-DME that was supplemented with T3 and T4 were employed in various experiments as described below. The free T3 and free T4 fractions in RT-DME that was supplemented with various concentrations ofT3 and T4 were also measured by the ultrafiltration method (22) . The concentrations of free T3 and free T4 in RT-DME that was supplemented with T3 and T4 were calculated from the product of T3 and T4 concentrations in the medium and the respective free fraction for each iodothyronine.
Occupancy of T13 receptors by iodothyronines. GC cells were incubated in 6-cm diam culture dishes with 10 ml of RT-DME supplemented with T4, T3, ['25I]T4, and [131 1T3. We used a medium-exchange protocol (30) to minimize the cellular uptake of T3 generated from T4 [T3(T4)] that was released into the medium. In this protocol, the medium was exchanged every 10 h with 10 ml per dish of fresh and identical medium that was devoid of T3(T4), as previously described (30) . We have shown that this procedure limits the contribution of T3(T4) to < 16% of the total medium T3 (30) .
Initial studies were done to determine the time of equilibration between nuclear and medium iodothyronines. In subsequent studies, cells were harvested after 24 h of incubation, a time when equilibrium between medium iodothyronines and cellular pools had been attained (See Results). The nuclear fraction was prepared (30) and assayed for radioactivity in an Autogamma Spectrometer (Packard Instruments Co., Downers Grove, Il). The counts per minute in the 1251 channel was corrected for counts per minute of'3I that appeared in the 125I channel. Nuclear iodothyronines were then extracted by addition of 0.5 ml of 85% ethanol for 16 h at 20'C. < 5% of the 125I or 131I remained in the nuclear pellet after this procedure. Nuclear extracts were evaporated under a stream of N2, resuspended in 50-100 Ml of methanol/NH3 (95:5, vol/vol). Samples were applied to Whatman 3 paper for descending chromatography in t-amyl alcohol/NH3/hexane (5:6:1, vol/vol/vol) at 370C as previously described (22) . After chromatography, the paper was dried and the location ofiodide, T4, and T3 was identified (22) . The counts per minute corresponding to each component was then determined as described (22) . Moles ofT3(T4) in individual nuclear samples was calculated from the product of the total counts per minute of 1251, the percentage of total counts per minute corresponding to [12511]T3, determined by chromatography, and the specific activity ofmedium T4 in each experiment. The result was then multiplied by 2 since only one half of the T3 molecules generated from [1251]T4 are radiolabeled (31) . The moles ofexchangeable T3 [T3(T3)] and the moles ofT4 in a specific nuclear fraction were determined after paper chromatography as described above. The nonspecific binding of T3(T3), T3(T4), and T4 in the nuclear fraction was measured by incubating the cells with 3,000 nM T3. Nonspecific binding was always < 5% of the nuclear counts for T3(T3), T3(T4), and T4. Nonspecific conversion of T4 to T3 was measured by incubating medium without cells at 37°C. Nonspecific conversion was < 0.05% of the counts added to the medium.
Interaction ofT3 and T4 with T3 nuclear receptors. T3 nuclear receptor binding capacity was determined in each experiment. Dishes ofGC cells were incubated for 24 h with different T3 and T4 concentrations according to the medium exchange protocol (30) . After 24 h, cells were rinsed with serum-free medium and then incubated for 3 h with 5 nM
[1251I]T3 at 370C. Under these conditions, > 90% of T3 receptors are occupied with T3. Cells were then harvested, and nuclei were isolated and assayed for radioactivity. Nonspecific binding was always < 5% of total binding. TR affinity for T3 and T4 in GC cells nuclear extracts. Nuclear extracts were prepared as previously described (26) . 200 Ml of nuclear extract supplemented with 10 pM [125I]T3 and 0-5 nM nonradioactive T3 or 0.2-500 nM nonradioactive T4 in a total volume of 0.5 ml of 20 mM Tris/HCl, pH 7.8, 0.4M NaCl, and 5 mM dithiothreitol were incubated for 72 h at 0°C. Nonspecific binding, < 10% oftotal binding, was determined as previously described (32) . At the end of incubation, receptor-bound [1251I]T3 was separated from free [1251]T3 with Dowex 1 x8, 400-mesh anion exchange resin as described (32) 
Results
Medium free T4 and T3 concentrations. Since GC cells were originally cloned from a rat GH-producing pituitary tumor, the relative roles of T3 and T4 in TR occupancy for the euthyroid state should be determined in incubations with physiological free T3 and free T4 concentrations. Initial studies were, there- Serum was collected from normal rats. Serum T3 and T4 were measured by radioimmunoassay and the free hormone fractions were measured by ultrafiltration ofundiluted serum. Entries are mean±SE (n = 9).
fore, designed to measure the free T3 and free T4 concentration ofrat serum so that these concentrations could be duplicated in tissue culture medium ( Table I ). The intensity of rat serum protein binding ofT4 and T3, was determined by ultrafiltration ofundiluted serum. The bound/free ratio was 3,845 for T4 and 120 for T3. Thus, the intensity of T4 binding by rat serum proteins was 32-fold greater than that of T3. Mean rat serum free T3 and free T4 concentration were 8.8±2.2 and 15.4±1.7 pM, respectively (P < 0.001).
The concentration of T3 and T4 in RT-DME that would result in free T3 and free T4 concentrations similar to physiological free T3 and free T4 concentrations of rat serum was determined by measuring free T3 and free T4 in RT-DME that was enriched with increasing concentrations of T3 and T4 (Fig. 2) . In this experiment, supplementation ofRT-DME with 1 10 pM T3 and 1.4 nM T4 resulted in medium free T3 (MFT3) and medium free T4 (MFT4) concentrations that were the same as the respective free hormone concentrations in rat serum. During these studies, we noted some variability in the concentration of medium T3 and T4 that were necessary to establish physiological conditions. Further experiments revealed that treatment of calf serum with resin to deplete serum of thyroid hormones resulted in a variable decrease in binding of T4 and T3 (Table II) . Because of this variability, unless otherwise indicated, experimental media used in these studies were studied as in Fig. 2 in order to be certain that MFT3 and MFT4 were similar to those in rat serum.
Occupancy of nuclear receptors by T4. Initial studies were done to determine the time at which equilibrium had occurred between nuclear and medium iodothyronines in incubations of GC cells employing the medium exchange protocol (Table III) .
Receptor occupancy by T3(T3), T3(T4), and T4 achieved after 22 h ofincubation was equivalent to that achieved after 28 h of incubation. These findings suggested that medium iodothyronines were equilibrated with nuclear iodothyronines after 22 h ofincubation. All subsequent studies were therefore carried out after 24 h of incubation.
The occupancy ofnuclear TR by T4 was studied in GC cells cultured with near-physiological MFT3, achieved by supplementing RT-DME with 85 pM T3, and with different concentrations ofmedium T4, 0.5-5.0 nM. These medium T4 concentrations were selected because they were both below and above 1.4 nM, the concentration that results in physiological free T4, (15.4 pM). As seen in Fig. 3 TR, [TRUJ, can readily be determined experimentally as in Fig.   3 . Ka for T3, KaT3, was determined by Scatchard analysis in nuclear extracts ofGC cells (Fig. 4) 
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Bound T3 (fmol) Figure 4 . Scatchard analysis of T3 binding to T3 receptors in nuclear extracts. GC cells were cultured with NS-DME for 48 h. Cells were harvested and nuclear extracts prepared as described in Methods. Each point is the average of two measurements which differed < 10%.
( Since free T4 is concentrated in the nucleus to a greater extent than free T3, as suggested from our studies employing nuclear extracts, the concentration ofT4 in medium relative to T3 that would be necessary to displace T3 from nuclear TR in intact cells should be significantly smaller than that observed in nuclear extracts (T4 42.0±1.2-fold > T3). The displacement of ['25I]T3 from TR by T3 and T4 was, therefore, studied in GC cells which were incubated with 10 1uM iopanoic acid to inhibit T3 production from T4. Preliminary experiments showed that incubation with 10 1sM iopanoic acid decreased nuclear T3(T4) to less than 3% of that found in control cultures incubated in the absence of iopanoic acid. The maximal amount of T3 generated from T4 under these experimental conditions was insufficient to displace [1251I]T3 from TR. Secondly, studies using nuclear extracts revealed that iopanoic acid did not influence the interaction of either T3 or T4 with TR. Lastly, studies with intact GC cells showed that iopanoic acid did not alter the concentration of T3(T3) or T4 in the nucleus.
A representative study of T4 and T3 interaction with TR in intact cells, shown in Fig. 6 , indicates that the concentration of T4 required for 50% displacement of ['25I]T3 from nuclear TR was 8.3-fold greater than the concentration of T3 required for 50% displacement of ['23IIT3. The mean value was 9.1±1.5-fold (n = 3), significantly smaller than observed in studies employing nuclear extracts, 42.0±1.2-fold (P < 0.001).
Relationship between medium T4 and NFT4. We used data from the experiment shown in Fig. 3 and the apparent equilibrium association constant for T3 and T4, listed above, to determine whether changes in medium T4 concentration would be reflected by comparable changes in NFT4 (Table V) . GC cells were incubated with 0.085 nM T3, which resulted in near-physiological MFT3. NFT3 was about five-fold greater than MFT3 and was not influenced by increasing medium T4, over a wide range. Increasing medium T4 from 0.5 to 5.0 nM resulted in parallel changes in NFT4. NFT4 always exceeded NFT3. At physiological MFT4, observed in incubations with 1.25 nM T4, NFT4 was 4.9-fold greater than NFT3.
T4 occupancy ofnuclear TR when medium T3 is decreased. Two experiments were carried out to determine the occupancy of TR by T4 and T3(T4) when medium T3 was decreased, an experimental protocol that has relevance to sick patients with decreased serum free T3 (Table VI) . The total number of TR was not influenced by changes in medium T4 and T3 in these experiments. However, a decrease in medium T3 from physiological levels, 0.11 nM, to 0.03 nM resulted in a significant decrease in abundance oftotal occupied TR (Table VI, B) . TR occupied by T3(T3) decreased and TR occupied by T3(T4) increased significantly even in the absence ofchanges ofmedium T4. When medium T4 was increased from 1.4 to 2.8 nM, in the continuing presence of decreased medium T3, TR total occu- Nuclear free iodothyronine concentrations were calculated as described in Results using the mass action equation. Medium free iodothyronine concentration was determined from the product of the iodothyronine concentration and the free iodothyronine fraction which was measured by ultrafiltration. Entries are mean±SE (n = 3).
pancy was restored to or near control values (Table VI, C) . TR receptor occupancy was restored by a significant increase in occupancy by both T4 and T3(T4).
The decrease in TR total occupancy observed when medium T3 was decreased (Table VI, B) and the restoration ofTR occupancy to or near control values when medium T4 was increased (Table VI, C) were paralleled by significant changes in GH production. Nuclear free iodothyronine concentrations were calculated as described in Results using the mass action equation. Nuclear occupancy data were from the experiment depicted in Fig. 2 . Entries are mean±SE (n = 3).
tained when cells were exposed to medium free iodothyronine concentrations similar to those in euthyroid rat serum. Physiological medium free iodothyronine concentrations were achieved by supplementing RT-DME with between 90 and 1 15 pM T3 and 1.2-1.4 nM T4, concentrations that are significantly less than those reported previously to restore physiological concentrations (28) . This difference results from the new finding that treatment of calf serum with Dowex 1X8 anion exchange resin to deplete endogenous iodothyronines increases the free fraction of both T4 and T3. The present experiments, however, do not define whether this increase in free fraction results from depletion of iodothyronine binding proteins or other constituents of serum that facilitate binding of iodothyronines.
After incubation of GC cells with physiological MFT4 and MFT3 concentrations, T4 accounted for 5.4-10.0% ofthe occupied nuclear TR sites, a finding that is concordant with a previous reports concerning liver and kidney of euthyroid rats (15) . Exposure of cells to increasing MFI4 in the presence of near physiological MFT3 concentration resulted in a progressive increase in the contribution ofT4 and T3(T4) to nuclear TR occupancy and a modest decrease in occupancy by T3(T3). When GC cells were maintained in MFT4 concentrations that were fourfold greater than the euthyroid value, T4 itselfconstituted 20% of the iodothyronine bound to TR. Lastly, incubation with increasing MFT4 was associated with an increase in total receptor occupancy from 20-30% in cells maintained at physiological MFT4 to 35-45% in cells cultured with fourfold increased concentrations of MFT4. Thus, in addition to an important role as a prohormone for T3(T4) in GC cells, the present studies establish a role for T4 itself in thyroid hormone action in GC cells cultured with physiologic concentrations of MFT4 and MFT3 and a much larger role when MFT4 is selectively increased.
A common clinical setting that is associated with altered serum free iodothyronine concentrations is the euthyroid patient with acute nonthyroidal disease. Such patients are often characterized by decreased concentrations ofserum free T3 and either unchanged or increased concentrations of serum free T4 (20) (21) (22) 36) . A role for the normal or raised serum free T4 concentration in the maintenance of the euthyroid state in these patients has not been established. The present experiments suggest that T4 may play an important role in the maintenance of normal TR occupancy and biologic activity when MFT3 is decreased. A decrease in MFT3 without changing MFT4 was associated with a proportional decrease in T3(T3) bound to nuclear TR, partially offset by a significant increase GC cells were plated in NS-DME for 24 h. The cells were rinsed with serum-free medium and exposed to RT-DME supplemented with iodothyronine concentrations listed above. The medium-exchange procedure described in Methods was used to minimize the accumulation and cellular reuptake of T3(T4 in TR-associated T3(T4). Total nuclear TR occupancy by iodothyronines declined and this was paralleled by a decrease in GH production. The increase in T3(T4) bound to TR under these conditions could be due to development ofcellular hypothyroidism which has been associated with increased activity of type II T4-5' deiodinase (37) . Alternatively, the finding could be due to a decrease in product, (T3), inhibition of the enzyme. Published reports suggest the former possibility is more likely since T3 appears to have only minimal affect on enzyme activity (38) . When MFT4 concentration was increased to twofold the physiological value, nuclear TR occupancy and GH production were restored to or near the value observed when both MF74 and MFI3 concentrations were similar to those in euthyroid rat serum. Both T4 and a further increase in T3(T4) contributed nearly equally to the restoration of nuclear TR occupancy under these conditions. These findings indicate that increased MFT4 concentrations significantly affected TR occupancy and biologic activity in GC cells that were incubated with decreased MFT3. A similar role may be postulated for the raised serum free T4 concentration that occurs in many patients with nonthyroidal disease.
The significant contribution ofT4 to nuclear TR occupancy in the present studies prompted a reexamination ofTR interactions with T4 and T3. Studies of the relative concentrations of T4 and T3 that were required for 50% displacement of T3 from TR sites in nuclear extracts of GC cells revealed that the avidity of TR for T4 was only 2.4% that of T3. In the present studies, the avidity of nuclear sites for T4, 2-4% that of T3, was significantly less than reported for isolated rat liver nuclei, 8% that of T3 (39, 40) , nuclei from cultured GH, cells, 10% that of T3 (39), or for extracts of rat liver nuclei or GHI cell nuclei, 10% that of T3 (41) . Nuclear TR receptors have recently been shown to be the cellular homologues of c-erb A proto-oncogenes (42) and several forms of TR that bind T3, a l, 13, and 12, occur in different tissues. A number of these receptor forms from different tissues have been generated in vitro for studies of the binding of T3, T4, and iodothyronine analogues. A review of these data revealed a wide variation in the apparent avidity ofTR for T4 relative to T3 that was not segregated to specific receptor forms. For a TR forms, the T4 interaction relative to T3 was 3.7% for TR from rat brain (43) , 13 .3% for TR from chicken embryonic tissue (44), 2.3% for TR from human kidney (45) , and 11.5% for TR from rat liver (46) . For ,3 TR forms, the TR interaction relative to T3 was 17.9% for TR from human placenta (47) and 5% for TR from rat liver (46) . The wide variation in apparent avidity of different TR forms for T4 relative to T3 suggests that significant differences in reaction conditions prevailed in these published reports. The T3 content of T4 solutions was not mentioned in any of these reports. In our view, variable T3 contamination of T4 solutions that were used to displace T3 is a likely explanation for the differences between these studies. If the intrinsic avidity of TR sites for T4 is 2-3% that of T3, as in the present report and in the report of Nakai et al. (45) , 1-2% contamination of T4 solutions with T3 would result in a significant increase in the apparent avidity of receptor for T4. The magnitude of the affect of T3 contamination would also be dependent ofthe degree of saturation ofTR sites with radioactively labeled T3.
Using the apparent association constants of TR for T3 and T4, described herein, the calculated NFT3 was determined to be significantly greater than MFT3. This finding extends the observations of Oppenheimer and Schwartz (35) to cultured GC cells. The raised concentration ofNFT3 relative to MFT3 (3-6-fold) in cultured GC cells is appreciably smaller than reported for NFT3 in nuclei from rat liver, kidney, heart and brain (range: 50-250-fold) (35) but similar to the 7.6-fold gradient reported by Freake et al. (25) in cultured GH, cells. The present studies also suggest that free T4 is concentrated in GC cell nuclei (6-20-fold greater than MFT4) and to a greater extent than T3. Relative to MFT4 and MFT3 concentration, NFT4 was concentrated to 1.9-3.3-fold greater extent than NFT3. The conclusion that NFT4 was concentrated in nuclei to a greater extent than NFT3 was strengthened by data obtained in intact GC cells maintained in 10 gM iopanoic acid. The iopanoic acid decreased T3 production from T4 to < 3% ofcontrol values and neither influenced the avidity of TR for T3 or T4 nor the delivery ofT4 into the cell. The results ofthese studies indicated that significantly smaller concentrations of T4 relative to T3 were required to displace T3 from TR sites in intact cells than in nuclear extracts. A likely explanation for the difference is that free T4 is concentrated to a greater extent than free T3 in intact cells.
The present results do not provide new information concerning the cellular mechanisms responsible for maintaining the increased NFT4 and NFT3 gradients. Oppenheimer and Schwartz (35) reported that the principle gradient for free T3 occurred between cytosol and nuclear compartments rather than between the plasma and cytosol compartments. They also suggested that the free T3 gradient was probably maintained by an energy-dependent process (35) . The finding that free T4 gradients occur between nuclei and medium free T4 in cultured GC cells and that the free T4 gradients are larger than comparable gradients for free T3 raise the possibility that separate transporters may exist for the two iodothyronines or that the affinity of a common transporter for T4 is larger than for T3.
